TP53 and neoplasm: Consistent with a tumor suppressor function, the TP53 gene is mutated in more than half of all sporadic cancers and patients with Li‐Fraumeni syndrome (who are cancer prone) harbor germline TP53 mutations (Kastenhuber and Lowe, 2017).